Cognition Therapeutics shares are trading lower after Cantor Fitzgerald downgraded the stock from Overweight to Neutral.
Portfolio Pulse from Benzinga Newsdesk
Cognition Therapeutics shares are trading lower after Cantor Fitzgerald downgraded the stock from Overweight to Neutral.
July 30, 2024 | 11:53 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Cognition Therapeutics shares are trading lower following a downgrade by Cantor Fitzgerald from Overweight to Neutral.
The downgrade from a reputable firm like Cantor Fitzgerald is likely to negatively impact investor sentiment and lead to a short-term decline in CGTX's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100